Abstract
This paper details the potential for the use of remote data entry and a relational computerized data base of new drug data and the means to speed its analysis and review. The potential savings in accuracy, management, and time is enormous. The principles and early use of these systems are reviewed.
Keywords
Get full access to this article
View all access options for this article.
